Adimmune Owners | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Adimmune Corp.

Adimmune Corp. | Ownership

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Pheim Asset Management Sdn. Bhd.

53,000

0.02%

-22,000

0.09%

06/30/2017

Goldman Sachs Asset Management LP

6,000

04/30/2018

Pheim Asset Management (Asia) Pte Ltd.

-628,000

12/31/2017

View Profile

Address	No. 3, Sec. 1, Tanxing Road Taichung TX 427 23 Taiwan
Employees	-
Website	http://www.adimmune.com.tw
Updated	07/08/2019
Adimmune Corp. engages in the development, manufacture, and distribution of human vaccine. Its products include seasonal influenza vaccine, Japanese encephalitis vaccine, and tetanus toxoid alum precipitated. The company also provides fill and finish services, testing/analysis services, quality assurance courses, and consulting services.